Found: 104
Select item for more details and to access through your institution.
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 236, doi. 10.1007/s10637-016-0328-9
- By:
- Publication type:
- Article
PP069 Health Technology Assessment Of Radium-223 Dichloride In Resistant Metastatic Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
- Published in:
- BJU International, 2021, v. 128, n. 2, p. 254, doi. 10.1111/bju.15356
- By:
- Publication type:
- Article
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 764, doi. 10.1111/bju.12857
- By:
- Publication type:
- Article
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.
- Published in:
- PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0199642
- By:
- Publication type:
- Article
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12319-1
- By:
- Publication type:
- Article
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 3, p. e241215, doi. 10.1001/jamanetworkopen.2024.1215
- By:
- Publication type:
- Article
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345185, doi. 10.1001/jamanetworkopen.2023.45185
- By:
- Publication type:
- Article
Coronavirus: Older Persons With Cancer in Italy in the COVID-19 Pandemic.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00648
- By:
- Publication type:
- Article
Second-line treatment in renal cell carcinoma: clinical experience and decision making.
- Published in:
- Therapeutic Advances in Urology, 2021, v. 13, p. 1, doi. 10.1177/17562872211022870
- By:
- Publication type:
- Article
Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.
- Published in:
- Therapeutic Advances in Urology, 2016, v. 8, n. 5, p. 319, doi. 10.1177/1756287216656811
- By:
- Publication type:
- Article
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 2, p. 59, doi. 10.1177/1756287215571809
- By:
- Publication type:
- Article
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma.
- Published in:
- Therapeutic Advances in Urology, 2015, v. 7, n. 3, p. 152, doi. 10.1177/1756287215574457
- By:
- Publication type:
- Article
Experience with sorafenib in the treatment of advanced renal cell carcinoma.
- Published in:
- Therapeutic Advances in Urology, 2012, v. 4, n. 6, p. 303, doi. 10.1177/1756287212457216
- By:
- Publication type:
- Article
Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert.
- Published in:
- Therapeutic Advances in Urology, 2012, v. 4, n. 3, p. 107, doi. 10.1177/1756287212440302
- By:
- Publication type:
- Article
Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
- By:
- Publication type:
- Article
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1475, doi. 10.3390/ijms21041475
- By:
- Publication type:
- Article
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 17, p. 4263, doi. 10.3390/ijms20174263
- By:
- Publication type:
- Article
New formulation of the Navier–Stokes equations for liquid flows.
- Published in:
- Journal of Non-Equilibrium Thermodynamics, 2023, v. 48, n. 2, p. 207, doi. 10.1515/jnet-2022-0095
- By:
- Publication type:
- Article
Modal Representation of Inertial Effects in Fluid–Particle Interactions and the Regularity of the Memory Kernels.
- Published in:
- Fluids, 2023, v. 8, n. 3, p. 84, doi. 10.3390/fluids8030084
- By:
- Publication type:
- Article
Stochastic Modeling of Particle Transport in Confined Geometries: Problems and Peculiarities.
- Published in:
- Fluids, 2022, v. 7, n. 3, p. 105, doi. 10.3390/fluids7030105
- By:
- Publication type:
- Article
Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma.
- Published in:
- ImmunoTargets & Therapy, 2020, v. 9, p. 273, doi. 10.2147/ITT.S240889
- By:
- Publication type:
- Article
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156147
- By:
- Publication type:
- Article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
- Published in:
- Oncology, 2021, v. 99, n. 12, p. 747, doi. 10.1159/000515951
- By:
- Publication type:
- Article
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.
- Published in:
- Oncology, 2017, v. 92, n. 5, p. 269, doi. 10.1159/000455970
- By:
- Publication type:
- Article
Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients.
- Published in:
- Oncology, 2015, v. 88, n. 3, p. 133, doi. 10.1159/000367809
- By:
- Publication type:
- Article
Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology, 2012, v. 84, n. 1, p. 39, doi. 10.1159/000342768
- By:
- Publication type:
- Article
Pulmonary Carcinoid Tumours: Indolent but Not Benign.
- Published in:
- Oncology, 2007, v. 73, n. 3/4, p. 162, doi. 10.1159/000127382
- By:
- Publication type:
- Article
Safety and Activity of Sorafenib in Different Histotypes of Advanced Renal Cell Carcinoma.
- Published in:
- Oncology, 2007, v. 73, n. 3/4, p. 204, doi. 10.1159/000127387
- By:
- Publication type:
- Article
Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 6, p. 1, doi. 10.1002/ctm2.434
- By:
- Publication type:
- Article
Response to targeted therapy in urachal adenocarcinoma.
- Published in:
- Rare Tumors, 2014, v. 6, n. 4, p. 124, doi. 10.4081/rt.2014.5529
- By:
- Publication type:
- Article
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 3071, doi. 10.2147/CMAR.S360441
- By:
- Publication type:
- Article
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 6, p. 671, doi. 10.1007/s11912-023-01395-4
- By:
- Publication type:
- Article
Current Understanding of Urachal Adenocarcinoma and Management Strategy.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11912-020-0878-z
- By:
- Publication type:
- Article
Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 491, doi. 10.1634/theoncologist.2018-0787
- By:
- Publication type:
- Article
The Role of CT Imaging in Characterization of Small Renal Masses.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 3, p. 334, doi. 10.3390/diagnostics13030334
- By:
- Publication type:
- Article
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 1, p. 138, doi. 10.3390/diagnostics11010138
- By:
- Publication type:
- Article
Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 2167, doi. 10.2147/DDDT.S104225
- By:
- Publication type:
- Article
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083026
- By:
- Publication type:
- Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Costo-Efficacia di cabozantinib nel trattamento di prima linea del tumore a cellule renali avanzato (aRCC) in Italia.
- Published in:
- Giornale Italiano di Health Technology Assessment Delivery, 2020, v. 13, n. 7, p. 1
- By:
- Publication type:
- Article
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
- Published in:
- BJU International, 2012, v. 110, n. 7, p. 998, doi. 10.1111/j.1464-410X.2012.10970.x
- By:
- Publication type:
- Article
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
- Published in:
- BJU International, 2012, v. 110, n. 5, p. 692, doi. 10.1111/j.1464-410X.2012.10946.x
- By:
- Publication type:
- Article
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases.
- Published in:
- BJU International, 2011, v. 108, n. 8b, p. E250, doi. 10.1111/j.1464-410X.2011.10186.x
- By:
- Publication type:
- Article
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
- Published in:
- BJU International, 2011, v. 108, n. 2, p. 223, doi. 10.1111/j.1464-410X.2010.09825.x
- By:
- Publication type:
- Article
REPLY.
- Published in:
- BJU International, 2011, v. 107, n. 8, p. 1327, doi. 10.1111/j.1464-410X.2011.10270_2.x
- By:
- Publication type:
- Article
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?
- Published in:
- Drugs in R&D, 2017, v. 17, n. 3, p. 461, doi. 10.1007/s40268-017-0203-y
- By:
- Publication type:
- Article